Obrocea Mihail 4
4 · MAIA Biotechnology, Inc. · Filed Mar 10, 2023
Insider Transaction Report
Form 4
Obrocea Mihail
Chief Medical Officer
Transactions
- Award
Stock Options
2023-03-08+100,000→ 100,000 totalExercise: $4.10Exp: 2033-03-08→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.